All known American citizens detained in Venezuela have been freed by the interim administration, marking a significant shift following the political transition after former President Maduro's extradition.
China's factory activity unexpectedly contracted in January, official data shows, reversing a brief December expansion and underscoring persistent domestic demand challenges despite robust exports.
As Visa prepares to report its first-quarter results, investors are weighing its dividend strategy against earnings expectations. We break down the capital required to generate targeted monthly income from its payouts and what moving parts could affect the yield.
Shares of the flash memory leader surged after quarterly results demolished Wall Street estimates, fueled by insatiable demand from cloud and AI infrastructure builders.
Gulfport Energy (NYSE: GPOR) shares have surged roughly 200% over three years, yet a deep dive reveals conflicting signals. While a cash flow model suggests significant undervaluation, its price-to-sales ratio tells a more cautious tale, leaving investors to weigh the metrics against a volatile energy backdrop.
SoundHound AI expands its real-world footprint with a nationwide rollout of voice AI at Five Guys and partners with Bridgepointe Technologies to target the enterprise market, signaling a dual-path growth strategy.
Galderma Group's (SWX:GALD) shares have faced significant pressure in recent months, contrasting sharply with its strong yearly performance. This analysis delves into whether the current valuation presents a genuine entry point or reflects deeper concerns about the dermatology giant's ambitious growth narrative.
Barrick Gold (TSX:ABX) has delivered staggering returns of over 150% in five years, leaving investors to question if the rally has run its course. A deep dive into valuation models suggests the stock may still be trading at a significant discount to its intrinsic value.
Fair Isaac Corporation (FICO) shares have retreated from recent highs, prompting investors to reassess the valuation of the credit-scoring giant. With the stock down over 13% in the past month, we examine whether the dip presents a strategic entry point or confirms concerns that the rally has run its course.
Canadian National Railway is ramping up capital returns to shareholders through a significant new share repurchase program and a dividend increase, as the rail giant seeks to reassure investors following a period of underperformance in its stock price.
Defense giant Lockheed Martin secures a pivotal seven-year agreement to dramatically ramp up production of key missile defense systems while launching a new venture aimed at combating wildfires, signaling a dual-track strategy of reinforcing core government business and diversifying into civilian applications.
Samsara Inc. is emerging as the operational backbone for major food and beverage companies, driving tangible safety and efficiency gains. Yet, its stock appears undervalued against this growing strategic relevance in critical supply chains.
In a significant strategic shift, Hut 8 Corp. is decommissioning a key mining site and redirecting capital toward AI and high-performance computing infrastructure, signaling a move to diversify beyond volatile cryptocurrency markets.
Shares of Occidental Petroleum (OXY) have rallied roughly 10% over the last quarter, reigniting investor interest. As the oil giant aggressively pursues its Direct Air Capture ventures, analysts are divided on whether the current price of $45.39 reflects its true worth or overlooks significant long-term potential.
Terex Corporation's shares have experienced notable swings, declining over 4% last week but gaining nearly 7% in the past month. A fresh look at its valuation through discounted cash flow and peer comparisons suggests the stock may be trading at a significant discount to its intrinsic value.
Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) have surged over 50% in the last three months, reigniting debate over its fair value and the risks tied to its lead drug OJEMDA and a pivotal upcoming data readout.
Despite a robust drug pipeline and steady long-term gains, AstraZeneca's recent share price stagnation has investors questioning its true worth. A deep dive into valuation models suggests the pharmaceutical giant may be trading at a significant discount to its intrinsic value, even as its P/E ratio appears elevated compared to peers.
Bloom Energy's landmark $2.65 billion power agreement and a potential $5 billion infrastructure partnership signal a strategic pivot to become a cornerstone provider for the energy-hungry AI data center industry, prompting a fresh look at its long-term valuation.
The price tag for Dominion Energy's flagship Coastal Virginia Offshore Wind (CVOW) project has climbed by $300 million, reaching an estimated $11.5 billion. The utility cites new tariffs and a federal stop-work order as primary drivers for the latest cost overrun, even as construction resumes and the first power generation is imminent.
Initial unemployment filings in Missouri fell by nearly 25% last week, outpacing a modest national decline and contrasting with volatile swings in other states.
